ISR protects the public by managing and intensely supervising persons in the community while providing effective case management, therapeutic interventions and support to reduce

2020年7月17日 · The aim of the AGENT ISR randomised trial is to evaluate angiographic and clinical outcomes in patients with ISR of a previously treated lesion who were treated with …

This statewide program provides intensive supervision for the highest-risk individuals. Supervision includes four face-to-face contacts weekly, electronic home monitoring, mandatory work or …

AGENT is the first and only U.S. coronary drug-coated balloon (DCB), introducing a new treatment option for patients with in-stent restenosis (ISR). AGENT is purposefully designed to …

Intensive Supervised Release (ISR) The Intensive Supervision Program requires that very high-risk persons under supervision for violence or repeat sexual offending are placed on Intensive …

2024年11月6日 · 近日举行了由全军心血管疾病介入诊疗质控委员会主办、北部战区总医院心内科承办的支架内再狭窄（isr）病例研讨会暨agent药物球囊全国首批试用活动，大会主席是韩雅 …

2024年4月8日 · Patients with in-stent restenosis (ISR) within multiple layers of implanted stents pose a clinical challenge due to limited therapeutic options and high rates of recurrent …

For persons designated for ISR who have been assigned an agent but lack an approvable release plan, the caseworker and assigned supervision agent assist the person in locating an available …

AGENT ISR 随机试验的目的是评估先前治疗病变的 ISR 患者的血管造影和临床结果，这些患者接受带有新涂层配方的 DCB (Agent) 或标准 DC B (SeQuent Please) 治疗。方法和结果 AGENT …

2023年10月25日 · The AGENT IDE trial showed that the Agent DCB is superior to conventional balloon angioplasty in reducing target lesion failure for the treatment of coronary ISR. …